Wearables, Physical Activity, and Exercise Testing in Liver Disease

Area of Science:

• Hepatology
• Cardiology
• Metabolic Diseases

Background:

• Physical inactivity is a significant factor in the progression of advanced liver disease and metabolic syndrome.
• Nonalcoholic fatty liver disease is a growing cause of liver-related mortality globally.
• Patients are increasingly using wearable activity trackers to monitor physical activity for health improvement.

Purpose of the Study:

• To explore the role of physical activity in managing advanced liver disease.
• To highlight the utility of wearable activity trackers and cardiopulmonary exercise testing (CPET) in liver health.
• To emphasize the importance of a multidisciplinary approach in leveraging physical activity for patient benefit.

Main Methods:

• Review of current literature on physical activity, liver disease, and metabolic syndrome.
• Discussion of the application of wearable activity trackers for patient monitoring.
• Emphasis on cardiopulmonary exercise testing (CPET) for assessing cardiorespiratory fitness and predicting outcomes.

Main Results:

• Physical inactivity is a primary driver of liver disease deterioration and metabolic syndrome components.
• Wearable activity trackers offer a means for individuals to measure and improve physical activity levels.
• Cardiopulmonary exercise testing (CPET) demonstrates potential in risk stratification and outcome prediction in transplant hepatology.

Conclusions:

• Improving physical activity is crucial for enhancing cardiorespiratory fitness and managing liver disease.
• A collaborative approach involving patients, support networks, clinicians, and technology is essential for maximizing the benefits of physical activity interventions.
• CPET shows promise as a valuable tool in the assessment and management of patients with advanced liver disease.